Skip to main content
    H

    Hims Hers Health Inc (HIMS)

    Official site

    HEALTHCARE • HOUSEHOLD & PERSONAL PRODUCTS • NYSE

    $18.55
    -1.18 (-5.98%)

    Market Cap: $4.62B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Hims Hers Health Inc (HIMS) Earnings: Report Dates and Results

    Updated Nov 9, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Hims Hers Health (HIMS) is expected to report earnings on Feb 22, 2027. In the quarter ended Sep 30, 2026, Hims Hers Health reported EPS of $0.03, below the $0.07 estimate. It beat the EPS estimate in 4 of the 8 most recent quarters that had an estimate.

    Earnings

    Performance (10Y)

    Beat Rate
    48%(11/23)
    Avg Surprise
    +26.71%

    Upcoming Estimates

    Reports Feb 22, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus$0.12
    Range-$0.02 - $0.33
    15 analysts
    Revenue Consensus
    $924.38M
    Range$863.38M - $1.10B
    14 analysts
    Reports May 10, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$0.06
    Range-$0.20 - $0.01
    4 analysts
    EPS RevisionsNo revisions (30d)
    EPS Estimate DriftChange to current
    90d ago$0.07-197.3%
    60d ago$0.05-226.2%
    30d ago$0.05-226.2%
    7d ago$0.05-226.2%
    Current-$0.06
    Revenue Consensus
    $904.06M
    Range$860.90M - $953.50M
    5 analysts

    Next Report

    HIMS has an expected report date of Feb 22, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 50.0% above the $0.08 reported for the quarter ended Dec 31, 2025.

    HIMS Earnings Call

    The latest HIMS earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    Earnings History

    Of the 23 quarters below that had an estimate, HIMS beat 11 and missed 12. Revenue for the quarter ended Sep 30, 2026 was $890.37M, up 48.6% from $598.98M a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026$0.03$0.07-$0.05 - $0.20-57.14%Miss-50.0%110 up, 2 downNov 9, 2026$890.37M
    Jun 30, 2026-$0.10-$0.07N/A-42.86%Miss-134.5%20 up, 0 downAug 10, 2026$753.21M
    Mar 31, 2026-$0.40$0.03-$0.04 - $0.15N/AN/A-300.0%110 up, 0 downMay 11, 2026$608.10M
    Dec 31, 2025$0.08$0.04-$0.04 - $0.15+100.00%Beat-27.3%120 up, 8 downFeb 23, 2026$617.82M
    Sep 30, 2025$0.06$0.10$0.03 - $0.16-40.00%Miss-81.3%130 up, 10 downNov 3, 2025$598.98M
    Jun 30, 2025$0.29$0.23$0.20 - $0.27+26.09%Beat+383.3%41 up, 3 downAug 4, 2025$544.83M
    Mar 31, 2025$0.20$0.12N/A+66.67%Beat+300.0%61 up, 0 downMay 5, 2025$586.01M
    Dec 31, 2024$0.11$0.22$0.16 - $0.28-49.43%Miss+1000.0%40 up, 0 downFeb 24, 2025$481.14M
    Sep 30, 2024$0.32$0.05-$0.04 - $0.10+540.00%BeatN/A111 up, 0 downNov 4, 2024$401.56M
    Jun 30, 2024$0.06$0.05$0.02 - $0.06+20.00%BeatN/A110 up, 0 downAug 5, 2024$315.65M
    Mar 31, 2024$0.05$0.01-$0.04 - $0.03+400.00%Beat+66.7%100 up, 0 downMay 6, 2024$278.17M
    Dec 31, 2023$0.01-$0.02-$0.04 - -$0.01+150.00%BeatN/A70 up, 0 downFeb 26, 2024$246.62M
    Sep 30, 2023-$0.04-$0.03-$0.04 - -$0.02-33.33%MissN/A80 up, 0 downNov 6, 2023$226.70M
    Jun 30, 2023-$0.03-$0.04-$0.10 - -$0.03+25.00%BeatN/A70 up, 0 downAug 7, 2023$207.91M
    Mar 31, 2023$0.03$0.02N/A+50.00%BeatN/A72 up, 0 downMay 8, 2023$190.77M
    Dec 31, 2022-$0.05-$0.07-$0.11 - -$0.05+28.57%BeatN/A60 up, 0 downFeb 27, 2023$167.20M
    Sep 30, 2022-$0.09-$0.06N/A-50.00%MissN/A51 up, 0 downNov 7, 2022$144.84M
    Jun 30, 2022-$0.10-$0.09-$0.11 - -$0.05-11.11%MissN/A61 up, 0 downAug 8, 2022$113.56M
    Mar 31, 2022-$0.08-$0.06-$0.11 - -$0.05-33.33%MissN/A40 up, 0 downMay 9, 2022$101.31M
    Dec 31, 2021-$0.15-$0.07-$0.10 - -$0.06-114.29%MissN/A4N/AFeb 22, 2022$84.70M
    Sep 30, 2021-$0.10-$0.06-$0.08 - -$0.04-66.67%MissN/A3N/ANov 10, 2021$74.17M
    Jun 30, 2021-$0.09-$0.06-$0.16 - -$0.06-50.00%MissN/A3N/AAug 11, 2021$60.69M
    Mar 31, 2021-$0.28-$0.07-$0.20 - -$0.06-300.00%Miss-660.0%4N/AMay 17, 2021$52.31M
    Dec 31, 2020-$0.07-$0.16N/A+56.25%Beat-333.3%N/AN/AMar 18, 2021$41.47M
    Sep 30, 2020-$0.06N/AN/AN/AN/A-385.5%N/AN/ANov 12, 2020$41.32M
    Jun 30, 2020-$0.07N/AN/AN/AN/AN/AN/AN/AAug 13, 2020$35.90M
    Mar 31, 2020$0.05N/AN/AN/AN/AN/AN/AN/AMay 13, 2020$30.06M
    Dec 31, 2019$0.03N/AN/AN/AN/AN/AN/AN/AMar 27, 2020$24.77M
    Sep 30, 2019$0.02N/AN/AN/AN/AN/AN/AN/ANov 12, 2019N/A
    Jun 30, 2019-$0.24N/AN/AN/AN/AN/AN/AN/AAug 29, 2019N/A
    Mar 31, 2019-$0.27N/AN/AN/AN/AN/AN/AN/AJun 30, 2019$18.05M
    Dec 31, 2018-$0.27N/AN/AN/AN/AN/AN/AN/AMar 31, 2019N/A
    Last 32 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was $0.63, up 16.7% from the year before. It was -$0.27 for the year ended Dec 31, 2018, the oldest of the 8 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025$0.63+16.7%
    Dec 31, 2024$0.54N/A
    Dec 31, 2023-$0.03N/A
    Dec 31, 2022-$0.32N/A
    Dec 31, 2021-$0.62N/A
    Dec 31, 2020-$0.15N/A
    Dec 31, 2019-$0.46N/A
    Dec 31, 2018-$0.27N/A

    Earnings Calls

    The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 10,000 words across 10 speakers.

    CallPeriod endingWordsSpeakersTranscript
    2026Q3Sep 30, 202610,23510
    2026Q2Jun 30, 20269,59311
    2026Q1Mar 31, 202610,11512
    2025Q4Dec 31, 202510,13412
    2025Q3Sep 30, 20259,46311
    2025Q2Jun 30, 20258,91014
    2025Q1Mar 31, 20259,32213
    2024Q4Dec 31, 20247,8749

    2026Q3 Earnings Call

    Opening remarks

    William Newby Director of Investor Relations Good afternoon, everyone, and welcome to the Hims & Hers Health Third Quarter 2026 Earnings Call. On the call with me today is Andrew Dudum, our Co-Founder and Chief Executive Officer; Yemi Okupe, our Chief Financial Officer; and Mo Elshenawy, our Chief Technology Officer. Before I hand it over to Andrew, I need to remind you of legal safe harbor and cautionary declarations. Certain statements and projections of future results made in this presentation constitute forward-looking statements that are based on, among other things, our current market, competitors, and regulatory expectations, and are subject to risks and uncertainties that could cause actual results to vary materially. We take no obligation to update publicly any forward-looking statement after this call, whether as a result of new information, future events, changes in assumptions, or otherwise. The risks, uncertainties, and other factors that could cause actual results to differ from our forward-looking statements are described in our earnings release and SEC filings. Please see our recent earnings release and most recently filed 10-K and 10-Q reports for a discussion of these risk factors as they relate to forward-looking statements. In today's presentation, we also have certain non-GAAP financial measures. We refer you to the reconciliation tables to the most directly comparable GAAP financial measures contained in today's press release. You can find this information, as well as a link to today's webcast, at investors.hims.com. After the call, this webcast will be archived on the website for 12 months. And with that, I will turn the call over to Andrew.

    Andrew Dudum Co-Founder and CEO Thanks, Bill. Good afternoon, everyone, and thank you for joining us. This was a quarter of real progress toward building a company that we believe has never existed before: an everyday digital health platform that tens of millions of people rely on, not for a single treatment, but for the whole of how they take care of themselves. Before we turn to the quarter, I want to spend a few minutes on the thesis behind everything we're building because it explains both the results you're seeing today and the decisions we're making for the years ahead. Our conviction is simple. In health care, whoever owns the customer relationship wins. That's easy to say and very hard to do. Most companies in our industry build around a treatment, a condition, or a moment in time. They capture a single transaction, but then lose the thread. Customers want something different. They want a place that knows them, stays with them, and grows with them as their needs change.

    Frequently Asked Questions About HIMS

    When is Hims Hers Health's next earnings date?

    Hims Hers Health's next earnings report is expected for Feb 22, 2027.

    Did HIMS beat earnings estimates last quarter?

    No. Hims Hers Health reported EPS of $0.03 for the quarter ended Sep 30, 2026, below the $0.07 estimate by 57.14%.

    What EPS do analysts expect from HIMS next quarter?

    The consensus EPS estimate for Hims Hers Health for the quarter ending Dec 31, 2026 is $0.12 from 15 analysts, with estimates from -$0.02 to $0.33.

    How often does HIMS beat earnings estimates?

    Hims Hers Health beat the EPS estimate in 4 of the 8 most recent quarters that had an estimate, with an average surprise of +67.92%.